Dr. Alexander Teslenko was a senior scientist at the Central Institute for Pure Biological Substances of the Soviet Union in St. Petersburg for over twenty years. Dr. Teslenko has been researching therapies that penetrate the skin since the 1970s. He was the research director of the chief developers for vetdropTDA substances.
We have Dr. Teslenko asked in 2012 to explain something about Vetdrop in his words and this is an excerpt of his personal comments from the time he dealt with Vetdrop on a daily basis.
Dr. Teslenko, what makes the vetdropTDA system so special?
Dr. Teslenko: vetdrop TDA is the perfect symbiosis of physical and pharmaceutical administration. Our device contains individually adapted application programs for a wide variety of clinical indications and enables the physical application of pharmaceutical products in accordance with the matrix, while at the same time being adaptable to the treatment parameters of the respective product. It was important to us to make our research adaptable for practice, which is our first goal for all R&D.
What are the biggest challenges in the fight against chronic inflammation?
Dr. Teslenko: It is important to take care of the cells. Many competitors are developing substances that have a temporary effect by suppressing inflammatory processes. But they don't go to the source of the problem. With vetdrop TDA we always have the regenerative aspects of health care in mind. If you want to fight inflammation, you have to feed the cells with active substances and oxygen. That is exactly what vetdrop TDA does. The goal is measurable and sustainable health.
The key to health lies in the cell?
Dr. Teslenko: In a sense, yes. However, health is a relative term and is influenced by many parameters. It is important to have a holistic understanding of problem areas and the relationships within an organism. The vetdrop system not only combats hypoxia, which is harmful to cell biology, but also balances and manages free radicals and supplies the cells with essential nutrients, all with a very positive influence on the regenerative potential of the local system.
It all depends on the right mix?
Dr. Teslenko: Successful cell therapy for the regeneration of damaged structures requires many different factors, which we treat holistically with TDA. First of all, you have to get to the cell. Most technologies and applications fail here. TDA is more than just a "mixture" - it is a series of progressive processes that influence each other and act exponentially as a connection. These compounds are delivered directly to the cells. Our research has validated the regenerative power of TDA in long-term studies.